TECHNOLOGY

More news
James Tissot

Why eXoZymes Is Standing Out to Investor James Tissot

James Tissot, founder and author of Slack Capital, an independent research publication focused on uncovering asymmetric investment opportunities through high-conviction analysis, sees the emergence of eXoZymes (NASDAQ: EXOZ) as a different kind of biotech story.

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.